Found 401 matching trials
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations PHASE2 This is a single-center, open-label, phase I clinical trial aimed to evalua...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer PHASE1 This phase Ib trial finds the best dose and side effects of ensartinib and ...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer PHASE2 This is a multicenter, open-label, phase II clinical study conducted in Chi...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer PHASE1 This is a single center, open-label, nonrandomized, phase 1b study of TRC10...
Show More Location
UAB Comprehensive Cancer Center
Learn More & Join Trial
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer PHASE1 RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine, carbopla...
Show More Location
Cancer Institute of New Jersey at Hamilton
Learn More & Join Trial
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC PHASE3 This randomized, Phase III, multicenter, open-label study designed to evalu...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients PHASE2 The most likely way to improve survival and cure rates in treating ovarian ...
Show More Location
Gynecologic Oncology Associates
Learn More & Join Trial
Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients PHASE2 A phase II Study of an adapted chemotherapy regimen plus bevacizumab in eld...
Show More Location
Hospital Virgen de los Lirios
Learn More & Join Trial
Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study PHASE2 This is a prospective, multicenter, phase II study designed to evaluate the...
Show More Location
Jiangsu Cancer Hospital
Learn More & Join Trial
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer PHASE3 This randomized phase III trial studies carboplatin given together with pac...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial